Company intelligence / Profile preview

Verici Dx

Franklin, Tennessee, United Statesvericidx.com ↗
Ownership
Private
Development stage
Other
01

Overview

Verici Dx has developed and commercialized advanced diagnostic tests—Tutivia™ and Clarava™—for assessing the risk of acute rejection, chronic injury, and graft failure in kidney transplant patients. Tutivia™ demonstrated a significantly higher positive predictive value than existing single blood tests in an international multi-center validation study. Clarava™ showed promise in identifying pre-transplant patients at high risk of future rejection events. Protega™, a liquid biopsy test predicting fibrosis and long-term graft failure, is under development. The company’s products are offered as laboratory developed tests (LDTs) in the US under CLIA regulations; CE marking is being pursued for Europe.

Therapeutic areas
Nephrology
Modalities
Diagnostic testRNA signaturesArtificial intelligence-assisted transcriptomic analysis
Industry
Molecular Diagnostics
02

Partnerships

AKF – American Kidney FundASN – American Society of NephrologyAST – American Society of TransplantationASTS – American Society of Transplant SurgeonsKDIGO – Kidney Disease Improving Global OutcomesNKF – National Kidney Foundation

Beyond the preview

Go deeper on Verici Dx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verici Dx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call